CORT Q2 2021 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$92M+3.4% YoY

Gross Profit

$90M98.5% margin

Operating Income

$32M34.9% margin

Net Income

$27M29.0% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+15.3%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$44M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$568M

Total Liabilities

$46M

Stockholders' Equity

$523M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$89M	+3.4%
Gross Profit	$90M	$87M	+3.3%
Operating Income	$32M	$35M	-9.4%
Net Income	$27M	$28M	-6.4%